Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Priority Income Fund I Pref | PRIF-I | Nov 15, 2024 | 23.90 | 0.00 |
Priority Income Fund J Pref | PRIF-J | Nov 15, 2024 | 23.51 | +0.93 |
Priority Income Fund Pref | PRIF-H | Nov 15, 2024 | 24.08 | -0.86 |
Priority Technology | PRTH | Nov 15, 2024 | 7.99 | -2.80 |
Privia Health Group | PRVA | Nov 15, 2024 | 21.20 | -2.26 |
Pro-Dex | PDEX | Nov 15, 2024 | 46.11 | -3.56 |
ProAssurance | PRA | Nov 15, 2024 | 16.88 | +0.42 |
Procaps Group | PROC | Nov 15, 2024 | 0.69 | -13.21 |
Procept BioRobotics | PRCT | Nov 15, 2024 | 88.94 | +3.53 |
Processa Pharmaceuticals | PCSA | Nov 15, 2024 | 1.01 | -4.23 |
Procore Technologies | PCOR | Nov 15, 2024 | 69.15 | -3.44 |
Procter & Gamble | PG | Nov 15, 2024 | 169.54 | +1.47 |
Professional Diversity Network | IPDN | Nov 15, 2024 | 0.95 | +5.58 |
Proficient Auto Logistics | PAL | Nov 15, 2024 | 9.54 | +4.26 |
Profire Energy | PFIE | Nov 15, 2024 | 2.52 | -0.20 |
Profound Medical | PROF | Nov 15, 2024 | 8.01 | -0.02 |
ProFrac A | ACDC | Nov 15, 2024 | 6.43 | -4.17 |
PROG | PRG | Nov 15, 2024 | 47.72 | -0.15 |
Progress Software | PRGS | Nov 15, 2024 | 66.51 | -1.10 |
Progressive | PGR | Nov 15, 2024 | 255.78 | -0.67 |
Progyny | PGNY | Nov 15, 2024 | 13.77 | -1.50 |
ProKidney | PROK | Nov 15, 2024 | 1.70 | -21.16 |
Prologis | PLD | Nov 15, 2024 | 113.42 | -1.16 |
ProMIS Neurosciences | PMN | Nov 15, 2024 | 0.98 | -1.46 |
PropertyGuru | PGRU | Nov 15, 2024 | 6.65 | +0.15 |
ProPetro | PUMP | Nov 15, 2024 | 7.58 | -2.82 |
ProPhase Labs | PRPH | Nov 15, 2024 | 0.75 | -0.19 |
ProQR Therapeutics | PRQR | Nov 15, 2024 | 3.82 | -3.29 |
PROS | PRO | Nov 15, 2024 | 22.74 | -2.61 |
ProShares Bitcoin Strategy ETF | BITO | Nov 15, 2024 | 24.66 | +4.58 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.